Liu, H., Zask, A., Forouhar, F., Iketani, S., Williams, A., Vaz, D. R., Habashi, D., Choi, K., Resnick, S. J., Hong, S. J., Lovett, D. H., Bai, T., Chavez, A., Ho, D. D., & Stockwell, B. R. (2025). Development of small molecule non-covalent coronavirus 3CL protease inhibitors from DNA-encoded chemical library screening. Nature Communications, 16(1). https://doi.org/10.1038/s41467-024-55421-5

Falnikar, A., Quintremil, S., Zhao, H.-J., Cheng, H.-Y., Helmer, P., Tsai, J.-W., & Vallee, R. B. (2024). The nucleoporin Nup153 is the anchor for Kif1a during basal nuclear migration in brain progenitor cells. Cell Reports, 43(12), 115008. https://doi.org/10.1016/j.celrep.2024.115008

Maynard, R., Fitzgerald, A., Nasir, A., Eisman, S. E., Jablonski, S. A., Pearson, G., Mace, E., & Weiner, L. M. (2024). 1123 Promoting immune cell tumor invasion through forced overexpression of proteases. Regular and Young Investigator Award Abstracts, A1245–A1245. https://doi.org/10.1136/jitc-2024-sitc2024.1123

Clark, V. C., Strange, C., Strnad, P., Sanchez, A. J., Kwo, P., Pereira, V. M., van Hoek, B., Barjaktarevic, I., Corsico, A. G., Pons, M., Goldklang, M., Gray, M., Kuhn, B., Vargas, H. E., Vierling, J. M., Vuppalanchi, R., Brantly, M., Kappe, N., Chang, T., … Loomba, R. (2024). Fazirsiran for Adults With Alpha-1 Antitrypsin Deficiency Liver Disease: A Phase 2 Placebo Controlled Trial (SEQUOIA). Gastroenterology. https://doi.org/10.1053/j.gastro.2024.06.028

Sah, B., Singh, J., Shen, Y., Goldfarb, N., Samie, F. H., Geskin, L. J., & Liu, L. (2024). Loss of CELF2 promotes skin tumorigenesis and increases drug resistance. International Journal of Dermatology. Portico. https://doi.org/10.1111/ijd.17295

Cheng, K., Seita, Y., Whelan, E. C., Yokomizo, R., Hwang, Y. S., Rotolo, A., Krantz, I. D., Ginsberg, J. P., Kolon, T. F., Lal, P., Luo, X., Pierorazio, P. M., Linn, R. L., Ryeom, S., & Sasaki, K. (2024). Defining the cellular origin of seminoma by transcriptional and epigenetic mapping to the normal human germline. Cell Reports, 43(6), 114323. https://doi.org/10.1016/j.celrep.2024.114323

Costa, B. L. da, Quinn, P. M. J., Wu, W.-H., Liu, S., Nolan, N. D., Demirkol, A., Tsai, Y.-T., Caruso, S. M., Cabral, T., Wang, N.-K., & Tsang, S. H. (2024). Targeting miR-181a/b in retinitis pigmentosa: implications for disease progression and therapy. Cell & Bioscience, 14(1). https://doi.org/10.1186/s13578-024-01243-3

Gordillo-Sampedro, S., Antounians, L., Wei, W., Mufteev, M., Lendemeijer, B., Kushner, S. A., de Vrij, F. M. S., Zani, A., & Ellis, J. (2024). iPSC-derived healthy human astrocytes selectively load miRNAs targeting neuronal genes into extracellular vesicles. Molecular and Cellular Neuroscience, 129, 103933. https://doi.org/10.1016/j.mcn.2024.103933

Dubey, S., Chen, Z., Jiang, Y. J., Talis, A., Molotkov, A., Ali, A., Mintz, A., & Momen-Heravi, F. (2024). Small extracellular vesicles (sEVs)-based gene delivery platform for cell-specific CRISPR/Cas9 genome editing. Theranostics, 14(7), 2777–2793. https://doi.org/10.7150/thno.92133

Chen, Y., Zhang, K., Zhang, R., Wang, Z., Yang, L., Zhao, T., Zhang, S., Lin, Y., Zhao, H., Liu, Y., Wei, Y., Zhou, Y., Zhang, J., Ye, X., Zhao, J., Li, X., Que, J., Shi, S., & Liu, K. (2023). Targeting the SOX2/CDP protein complex with a peptide suppresses the malignant progression of esophageal squamous cell carcinoma. Cell Death Discovery, 9(1). https://doi.org/10.1038/s41420-023-01693-7

Shi, P., Murphy, M. R., Aparicio, A. O., Kesner, J. S., Fang, Z., Chen, Z., Trehan, A., Guo, Y., & Wu, X. (2023). Collateral activity of the CRISPR/RfxCas13d system in human cells. Communications Biology, 6(1). https://doi.org/10.1038/s42003-023-04708-2

Xiao, Y., Fang, H., Zhu, Y., Zhou, J., Dai, Z., Wang, H., Xia, Z., Tu, Z., & Leong, K. W. (2023). Multifunctional Cationic Hyperbranched Polyaminoglycosides that Target Multiple Mediators for Severe Abdominal Trauma Management. Advanced Science, 11(1). Portico. https://doi.org/10.1002/advs.202305273

Li, F., Chen, D., Sun, Q., Wu, J., Gan, Y., Leong, K. W., & Liang, X. (2023). MDM2‐Targeting Reassembly Peptide (TRAP) Nanoparticles for p53‐Based Cancer Therapy. Advanced Materials, 35(45). Portico. https://doi.org/10.1002/adma.202305164

Baranello, G., Chiriboga, C., Servais, L., Darras, B., Day, J., Deconinck, N., Farrar, M., Finkel, R., Bertini, E., Kirschner, J., Rasson, M., Mazurkiewicz-Bełdzińska, M., Vlodavets, D., Bader-Weder, S., Gorni, K., Jaber, B., Yeung, W., Papp, G., Scalco, R., & Mercuri, E. (2023). P230 Safety update: Risdiplam clinical trial program for spinal muscular atrophy (SMA). Neuromuscular Disorders, 33, S92–S93. https://doi.org/10.1016/j.nmd.2023.07.112

Li, T., Akinade, T., Zhou, J., Wang, H., Tong, Q., He, S., Rinebold, E., Valencia Salazar, L. E., Bhansali, D., Zhong, Y., Ruan, J., Du, J., Dalerba, P., & Leong, K. W. (2022). Therapeutic Nanocarriers Inhibit Chemotherapy‐Induced Breast Cancer Metastasis. Advanced Science, 9(33). Portico. https://doi.org/10.1002/advs.202203949

Geis, F. K., Sabo, Y., Chen, X., Li, Y., Lu, C., & Goff, S. P. (2022). CHAF1A/B mediate silencing of unintegrated HIV-1 DNAs early in infection. Proceedings of the National Academy of Sciences, 119(4). https://doi.org/10.1073/pnas.2116735119

Liu, Y., Wu, Z., Zhou, J., Ramadurai, D. K. A., Mortenson, K. L., Aguilera-Jimenez, E., Yan, Y., Yang, X., Taylor, A. M., Varley, K. E., Gertz, J., Choi, P. S., Cherniack, A. D., Chen, X., Bass, A. J., Bailey, S. D., & Zhang, X. (2021). A predominant enhancer co-amplified with the SOX2 oncogene is necessary and sufficient for its expression in squamous cancer. Nature Communications, 12(1). https://doi.org/10.1038/s41467-021-27055-4